Incidence of Primary (High-Grade Prostate Cancer) and Secondary Prostate Safety End Points
prostate
EVENTS, BENIGN PROSTATE HYPERPLASIA, BPH, PROSTATE
Discrete-time proportional hazards model estimates of hazard ratios (95% CIs) quantifying differential risk in testosterone replacement therapy (TRT) relative to placebo are shown in the forest plot. The hazard ratios are the hazard in the TRT group over the hazard in the placebo group, so a value greater than 1 indicates an excess of prostate events in the TRT group. BPH indicates benign prostate hyperplasia.